Fu-Shun Hsu
6PUBLICATIONS
5CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 13, 2021
PR-619, a General Inhibitor of Deubiquitylating Enzymes, Diminishes Cisplatin Resistance in Urothelial Carcinoma Cells through the Suppression of c-Myc: An In Vitro and In Vivo Study.Fu-Shun Hsu, Wei-Chou Lin, Kuan-Lin Kuo
|Nov 27, 2019
Author Correction: Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction.Fu-Shun Hsu, Chen-Wei Chou, Hong-Chiang Chang
|Nov 23, 2019
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study.Chung-Sheng Shi, Kuan-Lin Kuo, Mei-Sin Chen
|Jul 03, 2019
Trifluoperazine, an Antipsychotic Drug, Effectively Reduces Drug Resistance in Cisplatin-Resistant Urothelial Carcinoma Cells via Suppressing Bcl-xL: An In Vitro and In Vivo Study.Kuan-Lin Kuo, Shing-Hwa Liu, Wei-Chou Lin
|Apr 25, 2019
Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction.Fu-Shun Hsu, Chen-Wei Chou, Hong-Chiang Chang
|Mar 15, 2019
Histone Deacetylase Inhibitor, Trichostatin A, Synergistically Enhances Paclitaxel-Induced Cytotoxicity in Urothelial Carcinoma Cells by Suppressing the ERK Pathway.Fu-Shun Hsu, June-Tai Wu, Jing-Yi Lin
Pageof 1
